Understand the source comparison
Hexarelin Men Over 40: Protocol Comparison
Before selecting a research protocol, understanding how dosing frequency, timing, and cycling strategies impact growth hormone output and receptor sensitivity is essential. The table below compares three common hexarelin administration models used in metabolic
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a research protocol, understanding how dosing frequency, timing, and cycling strategies impact growth hormone output and receptor sensitivity is essential. The table below compares three common hexarelin administration models used in metabolic aging and body recomposition research.
- Single Daily Pulse
- Once daily
- Morning fasted (0–30 min post-waking)
- 200mcg subcutaneous
- 5 days on, 2 days off
- Researchers prioritizing simplicity and compliance; subjects with limited injection tolerance
- Produces one robust GH pulse daily. Restores some pulsatility but doesn't replicate natural biphasic rhythm; easier to maintain long-term
- Biphasic Pulse
- Twice daily
- Morning fasted + pre-bed (3+ hours post-meal)
- 100mcg per dose
- 4 weeks on, 1 week off
- Studies targeting circadian GH rhythm restoration; subjects willing to manage two daily injections
- Mimics natural pulsatile secretion most closely. Better sustained IGF-1 elevation over 8–12 weeks; higher compliance burden
- Intensive Cycling
- Morning fasted + pre-bed
- 150mcg per dose
- 2 weeks on, 1 week off
- Short-term body recomposition studies; research minimizing receptor desensitization risk
- Higher peak GH output with aggressive cycling to preserve receptor sensitivity. Not sustainable beyond 12–16 weeks; risk of rebound somatostatin tone
- The biphasic pulse protocol consistently outperforms single daily dosing for sustained IGF-1 elevation in men over 40. The second daily pulse restores the nocturnal GH surge aging suppresses. If injection frequency is a limiting factor, single daily dosing remains effective but produces a less physiological secretory pattern.